Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
The TRK-T1 oncogene, isolated from a human thyroid carcinoma, represents a rearranged form of the high affinity nerve growth factor (NGF) receptor encoded by the NTRK1 gene; it is created by an intrachromosomal rearrangement fusing the NTRK1 tyrosine ...
ORLANDI R +6 more
core
Zidesamtinib (Jideytro®): a new selective, brain-penetrant ROS1 inhibitor approved for the treatment of ROS1-positive non-small cell lung cancer. [PDF]
Lee S, Hu L.
europepmc +1 more source
Cancer control after pausing treatment with larotrectinib in responding children with sarcoma and a TRK fusion: a plain language summary. [PDF]
Mascarenhas L +7 more
europepmc +1 more source
RBPMS::NTRK3-rearranged sacral malignant spindle cell tumor in neurofibromatosis diagnosed by RNA sequencing: a case report and literature review. [PDF]
Chen C +5 more
europepmc +1 more source
Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data. [PDF]
Waguespack SG +17 more
europepmc +1 more source
Pan-TRK expression and NTRK gene aberrations in meningiomas: association with tumor grade and proliferative activity. [PDF]
Zhu Y +7 more
europepmc +1 more source
Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy. [PDF]
Yakoub MA +4 more
europepmc +1 more source
Multilocus Characterization Reveals Two Geographically Structured <i>Babesia</i> Lineages in Sheep from Southern and Southeastern Kazakhstan. [PDF]
Akhmetova A +7 more
europepmc +1 more source
Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity. [PDF]
Schwartz M +9 more
europepmc +1 more source
Molecular neurobiological insights on integrative role of Trk neurotrophic receptors and their small-molecule agonists in neurodegenerative conditions. [PDF]
Sanjai M +5 more
europepmc +1 more source

